The above button links to Coinbase. Yahoo Finance is not a broker-dealer or investment adviser and does not offer securities or cryptocurrencies for sale or facilitate trading. Coinbase pays us for ...

The above button links to Coinbase. Yahoo Finance is not a broker-dealer or investment adviser and does not offer securities or cryptocurrencies for sale or facilitate trading. Coinbase pays us for ...

Morningstar Quantitative Ratings for Stocks are generated using an algorithm that compares companies that are not under analyst coverage to peer companies that do receive analyst-driven ratings.

Stock futures cautious on Monday as investors reacted to a breakdown in peace talks between the U.S. and Iran over the weekend. Tensions spiked after President Donald Trump threatened a military ...

News is breaking today that Replimune Group, Inc.'s (REPL) Biologics License Application ("BLA") requesting approval for its drug candidate RP1 (vusolimogene oderparepvec) in the indication of anti-PD ...

April 10 (Reuters) - The U.S. Food and Drug Administration on Friday declined to approve Replimune's (REPL.O), opens new tab drug for advanced skin cancer, citing insufficient ‌data from studies, ...

©2021, EDGAR®Online, a division of Donnelley Financial Solutions. EDGAR® is a federally registered trademark of the U.S. Securities and Exchange Commission. EDGAR ...

Nasdaq provides company’s SEC filings, which are financial statements and reports filed electronically with the U.S. Securities and Exchange Commission (SEC) by Quotemedia. The SEC requires all ...

As shares of Replimune Group (REPL) hit an all-time low on Monday of $1.50 following the US FDA's rejection of its lead asset, the melanoma drug RP1, the Street is also turning negative on the company ...

Python remains on top despite another dip; C gains ground in second place, and April keeps the same top 10 order, with SQL, R, and Delphi holding steady. April’s TIOBE Index keeps the same cast in the ...